[1]
|
M. A. Scott and S. L. Stockham, “Basophils and Mast Cells,” In: B. V. Fedlman, O. W. Schalm, J. G. Zinkl and N. C. Jain, Eds., Schalm’s Veterinary Hematology, 5th Edition, Lippincott Williams & Wilkins, Baltimore, 2000, pp. 308-317.
|
[2]
|
K. Norrby, “Mast Cells and Angiogenesis,” Acta Pathologica Microbiologica et Immunologica Scandinavica, Vol. 110, No. 5, 2002, pp. 355-371.
doi:10.1034/j.1600-0463.2002.100501.x
|
[3]
|
S. Mukaratirwa, L. Chikafa, R. Dliwayo and N. Moyo, “Mast Cells and Angiogenesis in Canine Melanomas: Malignancy and Clinicopathological Factors,” Veterinary Dermatology, Vol. 17, No. 2, 2006, pp. 141-146.
doi:10.1111/j.1365-3164.2006.00505.x
|
[4]
|
L. M. Duncan, L. A. Richards and M. C. Mihn Jr., “Increased Mast Cell Density in Invasive Melanoma,” Journal of Cutaneous Pathology, Vol. 25, No. 1, 1998, pp. 11-15. doi:10.1111/j.1600-0560.1998.tb01683.x
|
[5]
|
S.-Y. Tan, Y. Fan, H.-S. Luo and Z.-X. Shen, “Prognostic Significance of Cell Infiltrations of Immunosurveillance in Colorectal Cancer,” World Journal of Gastroenterology, Vol. 11, No. 8, 2005, pp. 1210-1214.
doi:10.1177/104063870401600606
|
[6]
|
P. Schultheiss, “A Retrospective Study of Visceral and Nonvisceral Hemangiosarcoma and Hemangiomas in Domestic Animals,” Journal of Veterinary Diagnostic Investigation, Vol. 16, No. 6, 2004, pp. 522-526.
|
[7]
|
T. L. Gross, P. J. Ihrke, E. J. Walder and V. K. Affolter, “Skin Diseases of the Dog and Cat: Clinical and Histopathologic Diagnosis,” 2nd Edition, Blackwell Science, Oxford, 2006.
|
[8]
|
M. H. Goldschmidt and M. J. Hendrick, “Tumors of the Skin and Soft Tissues,” In: D. J. Meuren, Ed., Tumors in Domestic Animals, 4th Edition, Iowa State University Press, Ames, 2002, pp. 45-117.
|
[9]
|
A. M. Hargis, P. J. Ihrke, W. L. Spangler and A. A. Stannard, “A Retrospective Clinicopathologic Study of 212 Dogs with Cutaneous Hemangiomas and Hemangiosarcomas,” Veterinary Pathology, Vol. 29, No. 4, 1992, pp. 316-328. doi:10.1177/030098589202900406
|
[10]
|
M. Woldemeskel and S. Rajeev, “Mast Cells in Canine Cutaneous Hemangioma, Hemangiosarcoma and Mammary Tumors,” Veterinary Research Communications, Vol. 34, No. 2, 2010, pp. 153-160.
doi:10.1007/s11259-010-9341-1
|
[11]
|
S. Sabattini and G. Bettini, “An Immunohistochemical Analysis of Canine Haemangioma and Haemangiosarcoma,” Journal of Comparative Pathology, Vol. 140, No. 2-3, 2009, pp. 158-168. doi:10.1016/j.jcpa.2008.10.006
|
[12]
|
A. K. Abbas and A. H. Lichtman, “Cellular and Molecular Immunology,” 5th Edition, Elsevier Science, Philadelphia, 2003.
|
[13]
|
K. Yonemaru, H. Sakai, M. Murakami, T. Yanai and T. Masegi, “Expression of Vascular Endothelial Growth Factor, Basic Fibroblast Growth Factor, and Their Receptors (Flt-1, Flk-1, and Flg-1) in Canine Vascular Tumors,” Veterinary Pathology, Vol. 43, No. 6, 2006, pp. 971-980. doi:10.1354/vp.43-6-971
|
[14]
|
M. A. Grimbaldeston, J. J. Finlay-Jones and P. H. Hart, “Mast Cells in Photodamaged Skin: What Is Their Role in Skin Cancer?” Photochemical and Photobiological Sciences, Vol. 5, No. 2, 2006, pp. 177-183.
doi:10.1039/b504344a
|
[15]
|
H. Ward, L. E. Fox, M. B. Calderwood-Mays, A. S. Hammer and C. G. Couto, “Cutaneous Hemangiosarcoma in 25 Dogs: A Retrospective Study,” Journal of Veterinary Internal Medicine, Vol. 8, No. 5, 1994, pp. 345-348.
doi:10.1111/j.1939-1676.1994.tb03248.x
|
[16]
|
K.-B. Shiu, A. B. Flory, C. L. Anderson, J. Wypij, C. Saba, H. Wilson, I. Kurzman and R. Chun, “Predictors of Outcome in Dogs with Subcutaneous or Intramuscular Hemangiosarcoma,” Journal of the American Veterinary Medical Association, Vol. 238, No. 4, 2011, pp. 472-479.
doi:10.2460/javma.238.4.472
|